.
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T raditionally, clinical variables are used in medical practice to tailor interventions and determine prognosis concerning organ dysfunction and death. In chronic disease states, another outcome must be put in perspective, since medical technology can postpone death and minimize some organic complications, but throughout the lifetime the morbid condition affects many dimensions of patients' daily activities. In fact, quality of life is perceived by patients as being an important outcome in the scenario of chronic diseases.
Health-related (HRQOL) is associated with the various aspects of life that are affected by a person's health status 1 . During the 1990s there was a large increase in medical research about HRQOL 2 . Nowadays HRQOL, along with efficacy and security, is a primary outcome in many clinical trials. There are some well-validated instruments to measure HRQOL in patients as well as the general population. However, the high cost involved in validating such instruments inhibits creation of new instruments. SF-36 is being widely used in medical research and to measure population life quality parameters in many countries.
Amongst chronic diseases, end-stage renal disease (ESRD) deserves special attention in the context of HRQOL. ESRD affects quality of life more intensely than heart failure, diabetes, chronic lung disease, arthritis and cancer 3 . In addition, patients who perceive low HRQOL withdraw from dialysis treatment more frequently 4 . Perhaps no other marker can indicate this risk. Indeed, withdrawal is responsible for one-fourth of deaths in haemodialysis (HD) patients 5 . Unfortunately, kidney transplants, which offer the best life quality, are not accessible to many patients because of the worldwide shortage of organs 6, 7 . Hence, reliable associations of objective variables, such as from clinical or laboratory studies, are useful for health professionals involved in caring for HD patients.
Due to the multifactorial profile of HRQOL, it is not surprising that researchers find a multiplicity of associations, especially in multicentric studies with large samples 8 9 . This is a well-validated 36-item questionnaire covering issues relating to physical, psychological and social functioning that generates scores from 0 (worst) to 100 (best) concerning 8 domains: physical function (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social function (SF), role-emotional (RE) and mental health (MH). PF scores patients' I N V E S T I G A C I Ó N performance related to daily activities, RP regards the impact of physical health on life, BP evaluates pain level and its impact on normal daily activities, GH evaluates subjective perception about present and future health status and resistance to illness, VT scores patients' feelings about their energy, vitality and moments of fatigue, SF scores the impact of health on routine social activities, RE measures the influences of emotional status on daily activities, and MH scores humour and wellbeing, including depression and anxiety. Two nurses were trained in the use and purpose of the SF-36. The SF-36 was administered by the nurses and one author.
Patient data. The demographic data, time on dialysis and underlying aetiology of ESRD were assessed via unit records. Underlying kidney disease was classified by clinical criteria and not by histopathology. Educational level was graded as: 1 -up to 4 years of schooling; 2 -more than 4 years. Every patient was assigned a low, medium or high risk index based on comorbidity, as described by Khan et al 10 . Khan's comorbidity index takes into consideration age in three classes and nine comorbidities: diabetes, myocardial infarction, angina pectoris, congestive heart failure, liver cirrhosis, obstructive pulmonary disease, systemic collagen disease, pulmonary fibrosis and visceral malignancies. The laboratory results are those routinely measured in haemodialysis patients and correspond to the mean of three months, including the month when SF-36 was administered and the months before and after its administration. Creatinine, haemoglobin, albumin, calcium and phosphorus were measured with standard methods by the same laboratory throughout the study. KtV (dialysis dose index) was estimated using a second-generation Daugirdas formula 11 , and like other laboratory results, is presented as a three-month average.
Statistical analyses.
Continuous and category variables are presented as mean ± SD and percentages, respectively. Scores related to the eight domains of HRQOL were generated by a specific SF-36 programme. For univariate analysis, we calculated the Pearson correlation coefficient of age, time on dialysis and laboratory results with scores generated by the SF-36. We used the Spearman coefficient to estimate the correlation between comorbidity and HRQOL scores. For multivariate analysis, we employed stepwise linear regression including the following clinical and laboratory variables: sex, age, time on dialysis, comorbidity, creatinine, haemoglobin, albumin, calcium-phosphorus product and KtV. Statistical significance was considered to be a P value of <0.05. All the statistical analyses were carried out using the SPSS version 13.0 package programme.
RESULTS
The mean age of the sample was 43 ± 15 years (range 18-83), 64.6% were male, and mean time on dialysis was 39±44 months (median =19.0; range . The most prevalent primary kidney diseases were glomerulonephritis (49.4%) and hypertension (26.8%). The complete demographic and laboratory data are shown in Table 1 .
Amongst the eight domains related to quality of life, role-physical presented the lowest score (35.0±43.0) and social function the highest (64.3±27.7), as shown in Table 2 .
In the univariate analysis, all eight variables studied were correlated with at least one HRQOL domain. However, age (except for bodily pain) and albumin (except for role-emotional) were correlated with seven of eight domains. The correlations were negative for age and positive for albuminemia. The correlation coefficients are shown in Table 3 and 4. Comorbidity was associated with physical function, role-physical and roleemotional (Table 5) .
In the multivariate analysis, only age and albumin were associated with various life-quality domains. Nonetheless, time on dialysis, haemoglobin and calcium-phosphorus product were each associated with a specific domain, respectively, physical function, bodily pain and vitality, as shown in Table 6 .
DISCUSSION
Our sample is very singular: there were few diabetics, so young patients with predominance of glomerulonephritis as the primary kidney disease made up the majority, with a small number of
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participants with advanced comorbidity. The worldwide pattern is the reverse: diabetes is the principal primary kidney disease, with predominance of elderly and high-risk patients 12 .
This is a typical sample of underdeveloped areas of the globe, where infectious diseases are the main public health problem and medical assistance to patients with chronic diseases are inadequate. Indeed, diabetics in these regions die from cardiac complications before developing ESRD, which appears after many years the onset of diabetes. Brazil has socioeconomic disparities Data are means ± SD, or percentages (in parentheses) *Khan index
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and many regions due to its continental size, resulting in different profiles of haemodialysis patients. But even in larger and richer cities of southeast Brazil -and indeed in many large cities of the world -patients with the profile of ours can be found in poor and peripheral areas. Despite the underdeveloped profile, our HD patients presented role-physical as the lowest (worst) score and social function and mental health as the highest (best) scores. Role-physical pertains to physical, and social function and mental health to the mental component of HR-QOL. This is in accordance to North American and European results, which show mental aspects less affected than physical ones in HD patients 3, 13, 14 . Considering the young age and low-grade comorbidity of our patients, it is serious to find so much impact in the role-physical category. This smaller 
role-physical, together with poor social status and treatment restrictions, can be one determinant of the low percentage of patients with a job. Efficient interventions with physical conditioning programmes are reported in the literature 15, 16 . We think that better physical status will lead to more job opportunities amongst patients in such a productive age range. The quality of treatment evaluated by the laboratory variables can be considered good. The mean laboratory results are adequate to recommended targets for abuminemia and dose of dialysis 17 . The mean haemoglobin is 1 g/dl below the target. The calcium-phosphorus product is over recommended level, reflecting the difficulty in practice to control it adequately.
Age and albumin were the most important correlators with HRQOL. Their correlation was maintained in the multivariate model. Most information about the age effect on HRQOL comes from research on patients older than 65. In these, quality of life is lower than in the general agematched population 18, 19 . The average age of our sample is far below 65 and we found age negatively associated with both physical and mental aspects, in contrast to various studies where ageing affects more physical than mental components of quality of life 20, 21 . 
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Albumin is a traditional marker of morbidity and mortality 22 , and in our study it was positively associated with five of eight HRQOL domains. Its level decreases because of malnutrition or inflammatory activity. Unfortunately, a cross-sectional study design cannot clarify this association: Does low albumin affect HRQOL or low HRQOL interfere with diet, causing low albumin?
Comorbidity was correlated with three domains in the univariate analysis, but contrary to our expectations, not in the multivariate model. Probably this occurred because despite the grade of comorbidity, the consequences expressed by laboratory markers, such albumin, are the most important association. We can establish that HR-QOL in our sample can be more affected in patients with low albumin than those patients with comorbidities but without such alteration.
Calcium-phosphorus product, like albumin, is also a strong predictor of morbidity and mortality in HD patients 23 . This is derived from the deposition of calcium-phosphorus in soft tissues and also in arteries, affecting coronary and myocardial function, as well as causing ischemia of body segments 24 . Even though calcium-phosphorus product was associated with only one domain, we considered vitality a strategic domain, and believe this association has to be borne in mind by health providers treating patients with high calciumphosphorus product. We did not find this association in literature. Recent study reveals hypercalcaemia, but not calcium-phosphorus product, associated with poor mental health 25 .
It was surprising to us that time on dialysis was only associated with physical function, since time on dialysis is associated with so many medical complications. The median time on dialysis of only 19 months in our sample can be an explanation for the lack of this association.
We intentionally chose medical instead of socioeconomic factors to analyze due to the homogeneity of poor socioeconomic profile. It seems to us that some clinical variables studied can be modified, unlike the socioeconomic situation of our patients. The results reported here can improve the quality of care by achieving interventions concerning sub-groups at risk of poor outcomes. Control of diet and inflammation by checking albumin was always our concern and needs more attention regarding HRQOL. In the same way, control of calcium-phosphorus product gains importance in the perspective of life quality. Finally, the poor level related to rolephysical indicates the need for exercise programmmes, which have been shown to be efficient in literature.
There are several limitations to this study. Firstly, the sample size is modest. Secondly, our results may not hold for patients without the singular characteristics as ours. Thirdly, crosssectional evaluation makes it difficult to draw conclusions regarding causality by correlations and regression analysis. However, despite these limitations, the strength of our research regards its objective, in other words, the fact our analysis involves individual life quality domains helps to determine individual aspects of HRQOL which require priority attention by health care providers of similar patients.
In conclusion, clinical and laboratory variables such as age and albumin were significant and independently correlated with quality of life concerning almost all HRQOL domains assessed by SF-36. Vitality, a very strategic life-quality domain, was also associated with a third variable: the calcium-phosphorus product. Interventions must be planned to control albumin and calciumphosphorus product, as well as close follow-up of ageing in patients who remain on dialysis without transplantation. Finally, the very low score in rolephysical domain in such a youthful sample calls for particularly efficient interventions.
